Cationic porphyrins form stable complexes with oligodeoxynucleotides. To evaluate delivery, we used a 20mer phosphorothioate oligomer (Isis 3521) targeted to the 3′-untranslated region of the PKC-α mRNA, and complexed it with porphyrin. The expression of PKC-α protein and mRNA in T24 bladder carcinoma cells was reduced by ∼80 ± 10% at a concentration of oligomer of 3 µM, and 9 µM porphyrin. The expression of PKC-β1, -δ and -ε isoforms was unaffected by this treatment, but elimination of PKC-ζ protein and mRNA were observed. However, treatment with the porphyrin complex of Isis 3522, an oligomer which is directed at the 5′ coding region of the PKC-α mRNA, was equally effective as Isis 3521 with respect to PKC-α, but did not affect PKC-ζ protein or mRNA levels. Since Isis 3521 has an 11-base region of complementarity with the PKC-ζ mRNA, wheras Isis 3522 has only a 4-base region, the effect of Isis 3521 on PKC-ζ protein and mRNA expression may be due to irrelevant cleavage. Depending upon the desired application, this new strategy may offer several advantages over other methods of antisense oligodeoxynucleotide delivery including efficiency, stability, solubility, relatively low toxicity and serum compatibility. Porphyrins may thus be a potentially useful delivery vehicle for antisense therapeutics and/or target validation.
INTRODUCTION
Antisense oligonucleotides have been used successfully in many in vitro and in vivo systems as sequence specific inhibitors of gene expression (1) (2) (3) . The technology is useful not only for functional genomics, but has also been proposed as an anti-neoplastic therapeutic modality (4) . The most frequently utilized class of oligodeoxynucleotide are the relatively nuclease-resistant phosphorothioates, in which a sulfur atom substitutes for a non-bridging oxygen atom (5) . The intracellular half-life of this class of oligodeoxynucleotide is significantly increased versus phosphodiester oligonucleotides, and they have been convincingly shown, at least in some cases, to down-regulate the translation of targeted mRNA into protein with high specificity (1) (2) (3) . However, sub-optimal nuclear delivery of naked oligodeoxynucleotides (i.e. in the absence of some form of delivery vehicle) still restricts the general applicability of this technology.
The internalization of phosphorothioate oligodeoxynucleotides occurs by a combination of adsorptive endocytosis plus fluid phase endocytosis (pinocytosis) with the former probably predominating in cultured cells (6, 7) . However, both processes result in trapping of significant amounts of the oligodeoxynucleotide in intracellular vesicles. It may not be possible for the oligomers to emerge from these vesicles (i.e. endosomes and lysosomes) into the cytoplasm and hence the nucleus.
Several strategies have been employed to improve nuclear delivery of oligonucleotides. These are believed to succeed by increasing the permeability of the intracellular vesicles that entrap them. To date, the most widely used and successful approach involves complexation of oligodeoxynucleotides with cationic lipids, which enhances both their cellular uptake and activity (8, 9) . Other approaches employed to increase endosomal penetration have included complexation with cationic polyamines, for example poly-L-lysine and Starburst dendrimers (10) , and the mimicking of mechanisms of delivery of viral nucleic acids by the use of fusogenic peptides (11) . However, all these strategies are limited. The serum stability of the lipids is poor, and the vehicles themselves can be toxic. In LNCaP prostate cancer cells, for example, the number of convincing reports of antisense activity is very small, probably, as we have observed, due to the toxicity of the lipid delivery vehicle. Furthermore, in vivo pharmacokinetic parameters are suboptimal. This may be due to the formation of particulates from complexes of cationic lipids with oligodeoxynucleotides. These particulates can be phagocytosed by the reticuloendothelial system of intact organisms, thus limiting their bioavailability.
In the present work we describe the use of a potent new strategy for the delivery of oligonucleotides into cells based on the use of water-soluble cationic porphyrins. We focus on the properties of 5311 Nucleic Acids Research, 1994 , Vol. 22, No. 1 Nucleic Acids Research, 1998 meso tetra(4-methylpyridyl) porphine (TMP). However, we show an example where another porphyrin, meso tetraanilinium porphine (TAP) also has activity. These compounds are collectively known as Innophors, and a patent for their use as oligonucleotide delivery agents has recently been filed (12) . Because the purpose of this work was to evaluate a novel delivery vehicle, we utilized previously described antisense oligomers whose effects are generally considered to be reproducible, i.e. Isis 3521 and 3522 (13) (14) (15) . Both of these molecules are targeted to PKC-α, and show significant activity in tissue culture models. We demonstrate here that cationic porphyrins are able to form stable complexes with oligodeoxynucleotides, deliver them into cells, and promote highly specific activity consistent with an antisense mechanism of action.
MATERIALS AND METHODS

Cells
All cell lines were obtained from American Type Culture Collection (Rockville, MD). T24 cells were grown in McCoy's 5A medium (Gibco BRL, Grand Island, NY), containing 10% (v/v) heat inactivated (56_C) fetal bovine serum (FBS; Gibco BRL), supplemented with 25 mM HEPES, 100 U/ml penicillin G sodium and 100 µg/ml streptomycin sulfate. J82 cells were grown in Eagle's minimal essential medium (MEM) with Earle's salts supplemented with antibiotics as above, 2 mM glutamine, 1 mM pyruvate and 10% FBS. 5637 and LNCaP cells were grown in RPMI plus 10% FBS, supplemented by 1% non-essential amino acids, 1% pyruvate and antibiotics as above. Stock cultures were maintained at 37_C in a humidified 5% CO 2 incubator.
Reagents
Anti-PKC-α monoclonal antibody were purchased from Upstate Biotechnology (Lake Placid, NY). Anti-PKC-β1, -δ, -ε or -ζ polyclonal antibodies were purchased from Gibco BRL. Human PKC-α cDNA for northern analysis was a generous gift of Dr I. B. Weinstein (Columbia University). Rabbit PKC-ζ and PKC-λ/ι cDNAs were generously provided by Dr J. Moscat (Madrid, Spain). Lipofectin and Lipofectase were purchased from Gibco BRL and seventh generation Starburst dendrimers from Dendritech Inc. (Midland, MI). Transfections were performed in serum-free media as per the manufacturer's instructions. The transfection times for all these vehicles and the cationic porphyrins were identical (5 h) as was the subsequent incubation time before isolation of PKC-α protein.
Synthesis of oligonucleotides
The all-phosphorothioate oligonucleotides used in these studies were synthesized on an Applied Biosystems (Foster City, CA) model 380B DNA synthesizer by standard methods (5) . Sulfurization was performed using tetraethylthiuram disulfide/acetonitrile. Following cleavage from controlled pore glass support, oligodeoxynucleotides were base deblocked in ammonium hydroxide at 60_C for 8 h and purified by reversed-phase HPLC [0.1 M triethylammonium bicarbonate /acetonitrile; PRP-1 support]. Oligomers were detritylated in 3% acetic acid and precipitated with 2% lithium perchlorate/acetone, dissolved in sterile water and reprecipitated as the sodium salt from 1 M NaCl/ethanol. Concentrations of the full length species were determined by UV spectroscopy. 5′-32 P-labeled oligodeoxynucleotides were synthesized using T4 polynucleotide kinase and [γ-32 P]ATP.
The sequences of the phosphorothioate oligonucleotides used were: Isis 3521 (targeted to the 3′ region of the PKC-α mRNA), 5′-GTTCTCGCTGGTGAGTTTCA-3′; Isis 3522 (targeted to the AUG codon region), 5′-AAAACGTCAGCCATGGTCCC-3′. Control, scrambled oligonucleotide (CS) is 5′-CAGCCATGGTTC-CCCCCAAC-3′. The sequences of Isis 3521 mismatch control phosphorothioate oligonucleotides are:
3521, 5′-GTTCTCGCTGGTGAGTTTCA-3′; MC-1, 5′-GTT-CTCGTAGGTGAGTTTCA-3′; MC-2, 5′-GTTCTCGCTGGT-GATATTCA-3′; MC-3, 5′-GAACTCGCTGGTGAGTTTCA-3′; MC-4, 5′-GTTCTATCTGGTGAGTTTCA-3′; MC-5, 5′-GTTA-GCGCTGGACAGTTTCA-3′.
Porphyrins
TMP and TAP were purchased from Porphyrin Products (Logan, UT) and purified as described previously (12) . Oligomer-porphyrin complexes were formed in complete media at the stated concentrations and molar ratios.
Treatment of cells with oligonucleotide-porphyrin complexes
Cells were grown in 100 × 20 or 60 × 15 mm tissue culture dishes until 70-80% confluent. At this time, TMP or TAP (at the stated concentration) was diluted in 200 µl of complete medium, and oligonucleotide was added to give the required concentration of 3 µM. The solution was mixed gently and incubated at room temperature for 30 min to allow oligonucleotide-TMP complexes to form. Then, 1.8 ml of medium were added to the complex, mixed and overlaid onto the cells which were rinsed with fresh medium. The cells were incubated at 37_C for 5 h, washed once with complete medium to remove the TMP solution, and then allowed to incubate for additional 19 h.
Western blotting of PKC isozymes
Cells treated with oligomer-porphyrin complex were washed twice in cold PBS and then extracted in 100-150 ml of lysis buffer [50 mM Tris-HCl pH 7.5, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 1 mg/ml aprotinin, leupeptin, 1 mM Na 3 VO 4 , 1 mM NaF] at 4_C for 30 min. Cell debris was removed by centrifugation at 14 000 g for 20 min at 4_C. Protein concentrations were determined using the Bio-Rad protein assay system (Bio-Rad Laboratories, Richmond, CA).
Aliquots of cell extracts containing 25-40 µg of protein were resolved by 10% SDS-PAGE and transferred to Hybond ECL filter paper (Amersham, Arlington Heights, IL). Filters were incubated at room temperature for 1-2 h in Blotto 1 [5% non-fat milk powder in 50 mM Tris-HCl pH 7.5, 200 mM NaCl, 0.1% Triton X-100] and then probed with 1:500 dilution of PKC isoform-specific antisera in 1% BSA, 50 mM Tris-HCl pH 7.5, 200 mM NaCl and 0.02% NaN 3 . Membranes were then washed five times for 5 min each time with 50 mM Tris-HCl pH 7.5, 200 mM NaCl and 2% Triton X-100 and incubated in the same buffer containing 5% dry milk (Blotto 2) for 30 min at room temperature. The filters were then incubated for 1 h at room temperature in Blotto 2 containing a 1:10 000 dilution of peroxidase-conjugated goat anti-mouse or anti-rabbit secondary antibody (Amersham). They were washed five times and ECL was performed according to the manufacturer's instructions.
Determination of PKC isozyme mRNA
Cells were treated with complexes of oligodeoxynucleotides with TMP as described previously, and total cellular RNA was isolated using TRIZOL Reagent (Gibco BRL). Total RNA (20-30 µg) was resolved on 1.2% agarose gel containing 1.1% formaldehyde and transferred to Hybond-N nylon membranes (Amersham). Human PKC-α, -ζ or -λ/ι cDNA probes were 32 P-radiolabeled with [α-32 P]dCTP by random primer labeling using a commercially available kit (Promega) according to the manufacturer's instructions. The blots were then hybridized with these cDNA probes in 50% formamide, 5× SSC, 5× Denhard's solution, 0.5% SDS and 0.1 mg/ml of salmon sperm DNA overnight at 42_C. The filters were washed at room temperature twice for 15 min in 2× SSC and 0.1% SDS, once for 20 min in 1× SSC and 0.1% SDS, and finally twice for 15 min in 0.1× SSC and 0.1% SDS at 65_C. The filters were exposed to Kodak X-ray film with intensifying screens for 12-48 h at -70_C and developed.
Fluorescence titration
Fluorescence experiments were performed in a SPEX Fluorolog 2 spectrofluorimeter (Spex Industries, Edison, NJ). The excitation wavelength of fluorescein was 490 nm. The fluorescein and porphyrin emission wavelengths were 522 and 660 nm, respectively. A 15mer phosphorothioate homopolymer of thymidine, SdT15 (0.19 µM), was complexed by increasing the concentration of TMP or TAP at molar ratios (oligomer = 1) of 1:0.0125, 0.025, 0.05, 0.1, 0.25 and 0.5 in complete media. Emission spectra were recorded at room temperature, at 5 nm intervals between 510 and 700 nm. Curve fitting was performed with the Grafit program (Excel Software).
Confocal microscopy
T24 cells were seeded in glass bottom microwells and treated with complexes of fluorescein labeled oligodeoxynucleotides with TMP at 3:1 TMP:oligomer molar ratio at 37_C for 5 h in 120 µl wells. Cellular internalization was examined using an LSM 410 laser scanning confocal microscope (Zeiss, Thornwood, NY) equipped with a krypton/argon laser and attached to a Zeiss Axiovert 100 TV microscope. Two emission filters were used: 515-540 nm bandpass for fluorescein and 590 nm longpass for porphyrin. Usually, Z-series were taken of a 1-2 µm optical section at 2 µm intervals. For measurements, a maximum projection of all sections was used. Images were printed using NIH Software.
Gel electrophoresis
Complex formation of oligodeoxynucleotides with TMP was analyzed in native 20% polyacrylamide gels (polyacrylamide: bisacrylamide, 19:1) after electrophoresis in TBE buffer at room temperature. Gels were run at 10-15 V/cm, and the rate of migration of yellow bands of TMP in complexes with oligodeoxynucleotides at different TMP:oligo ratios were noted. In some experiments the bands were excised, eluted and subjected to repeat electrophoresis. 
S1 nuclease digestion
Complexes of 5′-32 P-labeled oligodeoxynucleotides with TMP at 0.5:1, 1:1, 2:1, 3:1 and 8:1 TMP:oligo ratios were dissolved in 15 µl of S1 nuclease buffer [30 mM sodium acetate pH 4.6, 1 mM zinc acetate, 5% (v/v) glycerol], and 27 U of the enzyme were added. The reaction was performed at 37_C for 3 min. The oligodeoxynucleotides were precipitated with 2% lithium perchlorate/acetone, dissolved in 5 µl formamide loading buffer, heated for 5 min at 90_C, cooled to 4_C, and analyzed by electrophoresis in 20% polyacrylamide-7 M urea sequencing gels. Figure 1 shows the structures of the porphyrins used in these studies. When an oligonucleotide-porphyrin complex is formed at a concentration <1 µM, the porphyrin Soret band at 425 nm shifts to longer wavelength (440 nm) and hypochromicity is observed. Titration of TMP (25 nM in PBS) with increasing concentrations of Isis 3521 also produced an increase in light absorbtion at 440 nm. (Fig. 2A) . A near isosbestic point is present at 435 nm until a concentration of 200 nM oligomer is attained. This suggests that multiple-site binding and/or complex aggregation does not occur at the lower concentrations.
RESULTS
Cationic porphyrins form complexes with oligodeoxynucleotides
A plot of λ 440 versus absorbance produces a curve mathematically consistent with there being single-site binding of the MichaelisMenton type (r 2 = 0.95; Fig. 2B ). However, this view must be qualified by the fact that we could not obtain any data points at oligomer or TMP concentrations of <25 nM because of interference at 440 nm by the uncomplexed TMP Soret band at 425 nm. Assuming that the curve in Figure 2B is indeed single site and non-sigmoidal (especially since porphyrin stacking should be minimal at this concentration), Lineweaver-Burke analysis of the data gave K d = 5-10 nM (Fig. 2B insert) . A similar experiment with Isis 3522 produced the same value of K d , also with the same qualifications.
As described previously (15) , when increasing concentrations of TMP are titrated versus micromolar concentrations of oligomer, the Soret band absorbance continues to increase, but only until charge neutrality is attained. We have observed 
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identical spectroscopic results, but the concentrations of oligomer and porphyrin were an order of magnitude lower (not shown) than used previously. These data (in combinaton with the gel-shift data given below) strongly suggest that there are additional, lower affinity porphryin binding sites on the oligomer. Further addition of TMP does not produce any additional increase in this absorbtion, although stacking interactions between porphyrins may occur.
Size exclusion gel filtration experiments performed at room temperature using Sephadex G50 at low complex concentration (9 µM TMP/3 µM Isis 3521; PBS elution buffer, room temperature) demonstrated that virtually all the yellow complex that formed migrated through the gel at precisely the same rate as uncomplexed 32 P-labeled oligomer. In addition, all the 32 P label eluted with the porphyrin; none remained on the column. However, at higher complex concentration (25-200 µM), significant aggregation/precipitation occurred even at a TMP:oligomer molar ratio of only 2:1. These precipitates, in which all of the 32 P label could be found, would not enter PAGE gels, and could not be filtered through Sephadex G50. Because charge neutrality was not reached, and since free oligomer should have eluted, it is possible that the precipitated complexes may be composed of porphyrin-oligomer concatemers.
In non-denaturing PAGE gels, oligomers of different sequences exhibit slightly different migration patterns. At 2:1 and 3:1 TMP:Isis 3521 molar ratios, two distinct, yellow bands can be observed after electrophoresis (Fig. 3 , shown in black and white; under our experimental conditions, uncomplexed cationic porphyrins will not enter the gels). These distinct bands migrate slightly more slowly than does the uncomplexed oligomer. The faster migrating of the two bands, based on its rate of migration and the gel filtration experiments, probably represents a 1:1 complex. The slower moving band may represent a 2:1 complex, but this seems doubtful. Most likely, it may also be a 1:1 complex with altered porphyrin binding, perhaps to a different site on the oligomer. Both of these complexes are very stable in PBS (25_C); after elution from the gel and repeat PAGE, yellow bands with mobilities identical to those seen previously were observed. Similar observations were made with the TMP complex of Isis 3522 and the scrambled control for Isis 3521. However, other sequences did not always produce discrete banding patterns, and sometimes only smears were observed (not shown). These smears probably represented 'bleeding' of porphyrin from relatively low affinity binding sites on the oligonucleotide.
S1 nuclease digestion experiments demonstrate concentration-dependent protection by porphyrins
We determined the extent of 5′-32 P-end-labeled oligomer protection by increasing molar ratios of TMP/Isis 3521 via S1 nuclease digestion. Significant protection from digestion was observed, with gel band fragments corresponding to the 3′-terminal 4mer or shorter species being greatly diminished in intensity on the autoradiographs (not shown). However, protection was not due to the direct inhibition of the enzyme by TMP. We believe that this is true because in other experiments, significant, but not complete protection was observed up to a TMP:oligomer ratio of 30:1, but the extent of protection was not dependent on TMP concentration after charge neutrality had been attained.
Cationic porphyrins quench fluorescein fluorescence
We used measurements of fluorescence resonance energy transfer (FRET) to further study the interactions of porphyrins with oligodeoxynucleotides. The efficiency of FRET between a 5′-fluorescein labeled 15mer phosphorothioate (FSdT15) and TMP or TAP was evaluated by examination of the emission spectra from 510 to 700 nm at various porphyrin/oligomer molar ratios as described in the Materials and Methods. The fluorescein emission occurs at 522 nm, and binding of oligonucleotide or covalently attached fluorescein moiety to increasing concentrations of TMP or TAP resulted in progressive quenching of this emission. Even at a molar ratio of TMP:oligomer = 0.25 (1:4), 78% quenching was observed; at a ratio of 0.5, quenching was virtually 100% (not shown). Quenching with TAP was not as dramatic; at a TAP:oligomer ratio = 0.25, the fluorescence quenching was 35%, and 100% quenching occured at a molar ratio of unity.
Cationic porphyrins deliver oligonucleotides to the cell nucleus: confocal microscopic studies
The data in Figure 4 demonstrate that TMP effectively delivered fluoresceinated oligodeoxynucleotides to virtually all cell nuclei (fluorescein green fluorescence). Similar results were observed with TAP [Compare A1 with A2 (TMP used) and B1 with B2 (TAP used) in Fig. 4 ]. In the absence of cationic porphyrin, the naked oligonucleotides were taken up by the cells to a much lesser extent, and most of the internalized material was located in vesicular structures, which produced the typical, well described punctate staining pattern (not shown). Because fluorescein fluorescence is so effectively quenched by cationic porphyrins in vitro even at a 1:1 molar ratio (see above), the fact that the nuclei fluoresce green (Fig. 4, B1) indicates that the porphyrin had completely dissociated from the observed, fluorescent oligonucleotide (Fig. 4, C1 and C2 ).
Porphyrin-oligonucleotide complexes demonstrate antisense activity
Experiments using TMP and TAP to deliver antisense oligodeoxynucleotides were performed in T24, 5637 and J82 bladder carcinoma cells and in LNCaP prostate carcinoma cells with 20mer phosphorothioate oligodeoxynucleotides targeted to the PKC-α mRNA. Isis 3521 was targeted to the 3′-untranslated region of the PKC-α mRNA, and Isis 3522 was targeted to the initiation codon region. The optimum incubation time of the cells with complexes was 5 h, and expression of PKC-α protein was assayed by western blotting after a further 19 h incubation in complete media in the absence of complex.
Both oligomers when complexed to TMP or TAP were highly active ( Figs 5 and 6A ). Naked oligomers, even at higher concentration, were completely ineffective. Observations consistent with antisense activity were made over a relatively small concentration range (3-9 µM oligomer) and over a narrow molar ratio of TMP to oligomer (2-3.5:1). Complexes of TAP were active over the same concentration range. The expression of PKC-α protein for Isis 3521 delivery with TMP was reduced by 82 ± 11% (n = 12 for Isis 3521). The data for Isis 3522 were similar, but n = 5. The concentration was 3 µM oligomer/9 µM TMP. A control scrambled phosphorothioate oligomer complexed with TMP did not produce any reduction in target protein levels (Fig. 5) . Five control oligomers (MC-1, -2, -3, -4 and -5) with changes in two bases no longer led to any diminution of PKC-α protein expression (Fig. 5) . Moreover, as assessed by MTT assay, the TMP-oligomer complexes were not cytotoxic at the concentrations needed for maximal antisense efficacy. The kinetics of inhibition of PKC-α expression by Isis 3521 complexed with TMP are similar to those obtained when the oligomer is complexed with cationic lipids (14) . Maximal, but reversible, reduction in expression occurred after ∼24 h after complex addition. By ∼48 h after complex addition, PKC-α protein expression had returned almost to baseline. In order to determine isoform specificity of the inhibition of protein expression, the levels of several PKC isozyme proteins (classical isoform PKC β1 and non-classical isoforms δ, ε and ζ) were assayed by western blotting. In T24 cells, the TMP/Isis 3521 complex produced no diminution of levels of isoforms PKC-β1, δ or ε proteins (Fig. 5) . However, an ∼85-95% decrease of PKC-ζ protein levels was observed. Isis 3522, which was equally efficacious at reducing PKC-α protein expression, was entirely specific for PKC-α, and no diminution in PKC-ζ protein levels was observed.
By way of comparison, in our hands in T24 bladder carcinoma cells, the maximum tolerated Lipofectin concentration is 5 µg/ml. We treated these cells with Isis 3521 (0.4 µM) complexed with 5 µg/ml Lipofectin, but we could not obtain better than 50% antisense efficacy. Superior results have been reported by others, and the difference is most likely due to local conditions (see below).
In 5637 bladder carcinoma cells (Fig. 6B) , almost total inhibition of PKC-α expression was observed with a 2:1 molar ratio of TMP:Isis 3521 (2:1 µM), but only 50% inhibtion at a 4:1 molar ratio at the same oligomer concentration. A control oligomer was completely inactive. In J82 cells, however, optimized inhibition of protein expression was only ∼50% with TMP or TAP:Isis 3521 (4:1 µM). In UMUC cells, we obtained no inhibition of PKC-α protein expression with either delivery vehicle.
In sharp contrast, TMP complexes of Isis 3521 and Isis 3522 were completely inactive in LNCaP cells (Fig. 6C) . We also evaluated the ability of Lipofectin and Lipofectase to diminish PKC-α expression. LNCaP cells were transfected according to the manufacturer's instructions (5 µg/ml cationic lipid + 0.5 µM oligomer); higher concentrations of lipid were toxic. Diminution of PKC-α expression was observed on western blot with Isis 3521, but an equal decrease was seen with control oligomer + cationic lipid for both lipid vehicles. Seventh generation Starburst dendrimers were also evaluated as per the manufacturer's instructions at charge ratios (total charge dendrimer/total charge oligomer) of 1:10, 1:25 and 1:50. No toxicity was observed, but neither was any antisense effect. However, significant inhibition of target protein was observed with a 2:1 TAP:oligomer (2:1 µM) molar ratio (Fig. 6C) . A control oligomer in complex with TAP under identical conditions was inactive. Moreover, in contrast to other transfection strategies, the use of cationic porphyrins does not require serum-free conditions, which may be useful in a setting in which lengthy transfection times are required.
Northern blotting (Fig. 7) of T24 cell total RNA using a PKC-α specific cDNA full length probe revealed the two previously observed transcripts of 8.5 and 4.0 kb. Typically, these are expressed at 2:1 ratio, respectively. When T24 cells were treated with 9 µM TMP/3 µM Isis 3521 for 5 h, washed and then incubated for an additional 19 h, levels of both transcripts were decreased by 95-100%. The same mRNA samples were examined for the expression of PKC-ζ and PKC-λ/ι mRNA. The data shown in Figure 7 demonstrate that the expression of both the 4.0 and 2.2 kb PKC-ζ was reduced by >95%. This correlated with a similar decrease in PKC-ζ protein (see below), which had not been observed previously with Isis 3521. Under identical conditions, however, there was no effect on the expression of the 4.6 kb PKC-λ/ι mRNA transcript. PKC-α mRNA blots were then stripped and reprobed with a control glycerol-3-phosphate dehydrogenase cDNA probe (G3PDH). The data demonstrated Figure 7 . PKC isoform mRNA expression after treatment with Isis 3521. T24 cells were treated with Isis (3 µM)/TMP (9 µM), and mRNA was prepared as described in the text. Twenty-five micrograms of mRNA was loaded in each lane of the 1.2% agarose gels, transferred to Hybond-N nylon membranes, and probed with either a PKC-α, λ/ι, ζ or control G3PDH cDNA probe as described in the text.
essentially equal RNA loading in each lane, and no decrease in levels of this mRNA species.
DISCUSSION
Our initial intention was to produce a water-soluble, serum-stable oligonucleotide-vehicle complex for delivery into bladder carcinoma cells. Several investigators have shown previously that porphyrins, which may have a high avidity for tumor cells (16) bind to double-stranded (ds)DNA (17, 18) . In recent work, the cationic porphyrin mediated delivery of oligonucleotides to primary hepatocytes, NB4 promyelocytes, U-87 MG glioblastoma cells, CaCo-2 colon cancer cells, and several other lines, was observed (12) . Here, we describe the ability of cationic porphyrins to both deliver much lower concentrations of antisense oligonucleotides to cell nuclei, and to block genetic expression by a mechanism consistent with an antisense effect.
Binding occurs presumably due to an electrostatic interaction between the negative phosphorothioate groups of the oligomer and the cationic porphyrin. However, although the binding of cationic porphyrins to dsDNA has been well described (17) (18) (19) , almost no information is available about the binding of cationic porphyrins to single-stranded oligonucleotides.
It was not possible to obtain data on the binding of oligomers to porphyrins at a concentration of <25 nM porphyrin, perhaps because of the well known tendency of the porphyrin to adsorb on the walls of the cuvette (18, 19) . The apparent K d of binding of the initial molecule of porphyrin is 5-10 nM, if a single-site binding model with extrapolation to [TMP] = 0 is used to fit the data. This model is reasonable for three reasons: (i) little or no cooperativity would be expected for the interaction of TMP with an oligonucleotide, as opposed to dsDNA; (ii) the visible spectrum of the Soret bands observed in titration of oligomer with increasing concentrations of TMP shows a near isosbestic point, implying a simple monomer-dimer type equilibrium (18) and (iii) the 1:1 molar ratio complex of TMP with many 20mer oligomers of variable sequence migrate only slightly slower on non-denaturing PAGE gels than does the uncomplexed oligomer, which would be expected if the oligomer charge were reduced by binding of a single porphyrin. However, if the model is not valid, then the value determined for K d may in reality be an upper limit, but one which nevertheless is three orders of magnitude lower than the typical concentrations employed in tissue culture. It is also approximately three orders of magnitude lower than the K d for the binding of tetracationic porphyrins to dsDNA (∼1 µM) (20) .
Our gel retardation data demonstrate that the porphyrin-oligomer complex exists as a monomeric form (one molecule of porphyrin binding to one oligonucleotide molecule) at low porphyrin and oligomer concentration. At higher absolute concentration, aggregation/precipitation occurs, as it also does when the relative concentration of porphyrin alone is increased. Complex equilibrium mixtures undoubtedly exist in our experiments in complete media.
Resistance of oligomers in complex with cationic porphyrins to human serum nucleases has been observed previously (12) . We confirm this, and also have observed a significant decrease in the appearance of the radiolabeled 4mer and shorter fragments of S1 nuclease digestion of TMP/Isis 3521 as a function of TMP concentration. Since the radiolabel was present at the 5′ terminus, the absence of the shortest digestion products appears to indicate that the highest affinity porphyrin binding occurs at or near the 3′ terminus of the molecule, again probably by an electrostatic interaction. Protection from S1 digestion does not appear to increase as TMP concentration increases, implying that the protection was not due to direct inhibition of the enzyme by the porphyrin.
It is distinctly unusual for non-condensed DNA (i.e. monomers) to be able to cross the endosomal membrane to the extent observed in this study. However, as complex concentration increased, the tendency for it to aggregate also increased, though this aggregation occured at a concentration higher than we used in antisense experiments. Inside the endosome, however, a water shift into the cytoplasm occurs. Thus, the concentration of solute is increased greatly (21) , potentially leading to the formation of aggregates and precipitates of the porphyrin-oligomer complex. This may create the conditions necessary for the oligomer to transit the endosomal membrane, but although models have been proposed (22) it is not yet clear just precisely how this occurs. Regardless, it appears that once oligodeoxynucleotides enter the cytoplasm, translocation into the nucleus occurs rapidly (23, 24) .
The inhibition of PKC-α protein expression in bladder carcinoma cells is profound and highly reproducible provided the oligonucleotide is stored at a buffered pH of 7.5-8.0. If stored in water, the pH tends to decrease, and to a variable extent depurination will occur. We have found that oligomers with abasic sites cannot be delivered to cell nuclei using these porphyrin vehicles. The concentration range over which inhibition of gene expression is observed is narrower than it is for delivery using cationic lipids (e.g. Lipofectin), but for both, inhibition actually diminishes as concentration increases. This may be due to the fact that so much oligomer is being delivered to the nucleus that RNAse H activity, known to be sensitive to phosphorothioates and probably required for 'antisense' activity, is inhibited (25) .
The extent to which a fluoresceinated oligomer dissociates from the delivery vehicle intracellularly is also striking. Because of FRET, if the porphyrin remains associated with the oligomer, fluorescein fluorescence is virtually totally quenched. Thus, the bright green nuclear fluorescein fluorescence can only be observed subsequent to the physical separation of oligomer from the porphyrin, despite the nanomolar value of K d . (The infrequent yellow nuclear regions are probably due to the combination of green fluorescent oligonucleotide and red porphyrin fluorescence.) We believe that these are among the first data that demonstrate the intracellular dissociation of an oligomer from a delivery vehicle, and it appears that cationic lipids behave similarly (26) .
As shown by Dean et al. (13) (14) (15) , Isis 3521 is highly isoform specific. In that work, delivery was achieved by the use of a cationic lipid (Lipofectin). However, our data demonstrate that under somewhat different conditions (i.e. the use of a porphyrin vehicle and a higher oligonucleotide concentration), PKC-ζ protein and mRNA expression were down-regulated in tandem with PKC-α by this oligomer, which was targeted to the 3′-untranslated region of the mRNA. Such concurrent down-regulation did not occur with Isis 3522, which was targeted to the initiation codon region of the mRNA. The activity of Isis 3521 against PKC-ζ may be explained by the process of irrelevant cleavage, a concept first developed by Giles et al. (27) . There is a contiguous 11-base match between the anti-PKC-α oligomer Isis 3521 and the PKC-ζ mRNA. For Isis 3522, only 4-base matches occur. Indeed, only 4-to 5-base matching sequences are found with Isis 3521 and 3522 and the mRNAs of all other PKC isoforms, except PKC-ζ. Only a 7-base mRNA-oligo duplex appears to be necessary for mRNA cleavage to occur by the action of RNAse H (28). Because Isis 3521 (but not Isis 3522) contains an 11-base match with the PKC-ζ mRNA, it is possible that partial hybridization of the former species to the PKC-ζ mRNA and subsequent RNAse activation occurs.
Finally, a striking observation is the dependency of activity on both the identity of the porphyrin and the cell type. Thus, TMP and TAP produced 'antisense' effects in T24 cells. However, TMP was totally ineffective against the same target in LNCaP cells, in which only TAP was effective. In more recent work (I.Lebedeva, G.Takle and C.A.Stein, unpublished), we have targeted the LNCaP bcl-xL mRNA with 18mer phosphorothioate oligodeoxynucleotides, and found that complexes with TAP, but not TMP (or Lipofectin), generated active 'antisense' oligomers. Morever, these differences occured despite the fact that the K d of binding of the initial molecule of porphyrin to the oligomer was almost identical for both porphyrins, that both form aggregates with increasing concentrations of porphyrin as charge neutrality is approached and that the abilities to deliver oligomer to the nucleus are approximately equal. The identification of the reason underlying this difference is now being investigated intensively.
Thus, on the basis of these data, we conclude that cationic porphyrins cannot only deliver oligonucleotides to the nuclei of cells, but that they give rise to observations consistent with 'antisense' activity. They may also be useful in cells in tissue culture which are sensitive to the toxicity of cationic lipids and/or polyamines, or in which these vehicles are not active, or when serum-free transfection conditions cannot be used. Therefore, they can be regarded as additional and novel tools of great potential in the developing repertoire of chemical vehicles that deliver gene-targeted agents to the cell nucleus.
